- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05936008
Fitness After Stroke Trial (FAST)
Investigating Exercise Prescription Parameters on Aerobic Fitness and Vascular Health After Stroke: A Pilot Study
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
People with stroke often experience physical decline and aerobic fitness that can be reversed through exercise. Evidence has shown that participating in exercise benefits aerobic fitness and vascular health while less is known about brain health. However, the optimal exercise dose such as intensity and exercise type (continuous, interval) are not yet known.
The long-term goal of this project is to develop and test strategies to be implemented in larger clinical trials to improve health in people living with stroke. For this preliminary efficacy trial, the Investigator will enroll 50 participants with chronic stroke, age 20-85 years, into a 4-week exercise program. Participants will be allocated to one of the following groups using minimization, a type of randomization based on the lower extremity Fugl-Meyer score: 1) moderate intensity continuous training (MICT), that serves as the control, or 2) high-intensity interval training (HIIT). Exercise will be performed on a recumbent stepper. The Investigator will: Assess the preliminary efficacy of HIIT on aerobic fitness (Aim 1), cerebrovascular hemodynamics (Aim 2), and vascular function (Aim 3).
Current exercise recommendations for stroke use general exercise prescription principles for older adults and are not grounded on data generated from large, well-designed, randomized controlled trials in stroke. If aerobic exercise could be proven to reduce the number of "years of life lived with disability," it would offer a key strategy for: 1) minimizing dependence on caregiver support, 2) reducing overall healthcare costs, and 3) extending quality of life for individuals after stroke. This proposed trial will address an important gap in knowledge for both the scientific and clinical communities and provide essential data that will contribute to future exercise prescription recommendations focused on stroke.
Study Type
Enrollment (Actual)
Phase
- Phase 2
Contacts and Locations
Study Locations
-
-
Kansas
-
Kansas City, Kansas, United States, 66160
- University of Kansas Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Both sexes between the age of 20-85 years at time of consent
- Chronic ischemic or hemorrhagic stroke 6 months to 15 years at consent. People with stroke and newly diagnosed cardiovascular complications had >50% prevalence of recurrent stroke at 5 years. Index stroke or recurrent stroke on same side as index stroke will be allowed.
- Ability to walk over ground with assistive devices and no continuous physical assistance from another person to perform tests for gait speed and six-minute walk test
- Exercise continuously for minimum of 30 watts for 3 minutes on the recumbent stepper to demonstrate ability to perform the exercise test.
- No aerobic exercise contraindications or other safety/physical concerns during the submaximal exercise test.
- Able to communicate with investigators, follow 2-step command & correctly answer consent comprehension questions
- Currently participating in less than 150 minutes of physical activity/week assessed by the Rapid Assessment of Physical Activity
- Stable blood pressure & statin medication doses for 30 days prior to enrollment due to effects on vascular health/hemodynamics
Exclusion Criteria:
- Hospitalization for cardiac or pulmonary disease within past 3 months
- Implanted pacemaker or defibrillator limiting exercise performance
- Reported pain that limits or interferes with activities of daily living and physical activity/exercise
- Severe LE spasticity (Ashworth >2) due to inability to exercise
- Recent history (<3 months) of illicit drug or alcohol abuse or diagnosis of significant mental illness
- Major post-stroke depression (Patient Health Questionnaire, PHQ-9 ≥ 1084)
- Currently participating in physical therapy targeting lower extremity function or another interventional study that may influence study outcomes
- Other significant neurologic, orthopedic or peripheral vascular conditions that would limit exercise participation
- Oxygen-dependent chronic obstructive pulmonary disease
- Diagnosis of other neurological disease (Multiple Sclerosis, Alzheimer's disease, Parkinson's disease)
- Self report pregnancy
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Moderate intensity, continuous training (MICT)
After a 5-minute warm-up at 30% peak watts, MICT will consist of continuous exercise for 25 minutes at 55% of peak watts (range: 45%-65%).
The average heart rate for each individual session should not exceed 70% (60-70%) of HR maximum to align with current exercise recommendations for stroke.
An active cool-down (20% peak workload) at comfortable stepping pace occurs immediately after the intervention.
|
Standard of care, exercise recommendations for people with stroke
Other Names:
|
|
Active Comparator: High intensity, interval exercise (HIIT)
After the 5-minute warm-up at 30% peak watts, HIIT will consist of repeated 1-minute, high intensity bursts ("on" interval) alternated with 1-minute interval recovery ("off" interval) for 25 minutes.
The "on" interval will begin at 70% of peak watts (range: 65%-95%) followed by the "off" interval at 10% of peak watts.
The average HR for the "on" intervals will not exceed 85% age predicted maximum (75-85%).
There will be 13 minutes of "on" and 12 minutes of "off" interval exercise.
An active cool-down (20% peak workload) at comfortable stepping pace occurs immediately after the intervention.
|
The HIIT protocol consists of Short Interval, High Volume exercise at 1-minute exercise bouts followed by 1-minute active recovery for 25 minutes.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Oxygen uptake (VO2)
Time Frame: Baseline, 4 weeks
|
Assessing change in oxygen uptake during a submaximal exercise test
|
Baseline, 4 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Middle cerebral artery velocity
Time Frame: Baseline, 4 weeks
|
Assessing change in middle cerebral artery velocity response to an acute exercise bout
|
Baseline, 4 weeks
|
|
Middle cerebral artery velocity at rest
Time Frame: Baseline, 4 weeks
|
Assessing change in middle cerebral artery velocity during a rest condition
|
Baseline, 4 weeks
|
|
Flow-mediated Dilation
Time Frame: Baseline, 4 weeks
|
Endothelial vascular function
|
Baseline, 4 weeks
|
|
Pulse Wave Velocity
Time Frame: Baseline, 4 weeks
|
Arterial stiffness
|
Baseline, 4 weeks
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
6-Minute Walk Test (6MWT)
Time Frame: Baseline, 4 weeks
|
Walking endurance using the 6MWT
|
Baseline, 4 weeks
|
|
10-Meter Walk Test
Time Frame: Baseline, 4 weeks
|
Gait speed using the 10-Meter Walk Test
|
Baseline, 4 weeks
|
|
Cerebral Blood Flow
Time Frame: Baseline, 4 weeks
|
Global and regional blood flow using MRI
|
Baseline, 4 weeks
|
Collaborators and Investigators
Investigators
- Principal Investigator: Sandra A Billinger, PhD, KU Medical Center
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Cerebrovascular Disorders
- Brain Diseases
- Central Nervous System Diseases
- Nervous System Diseases
- Vascular Diseases
- Cardiovascular Diseases
- Behavior
- Ischemic Stroke
- Hemorrhagic Stroke
- Stroke
- Motor Activity
- Motor Activity
- Movement
- Musculoskeletal Physiological Phenomena
- Musculoskeletal and Neural Physiological Phenomena
- Exercise
Other Study ID Numbers
- STUDY00147598
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stroke
-
National Assembly ClinicBayero University Kano, NigeriaRecruitingStroke | Stroke Hemorrhagic | Stroke Ischemic | Hemiparesis After StrokeNigeria
-
University of PittsburghRecruitingHemorrhagic Stroke | Embolic Stroke of Undetermined Source | Ischemic Stroke, Cryptogenic | Recurrent Ischemic Stroke | Ischemic Stroke, EmbolicUnited States
-
Mahidol UniversityNot yet recruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke SurvivorsThailand
-
Mahidol UniversityRecruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke PatientThailand
-
University Hospital, GhentRecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Stroke HemorrhagicBelgium
-
Moleac Pte Ltd.Not yet recruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, Cryptogenic
-
Fondazione Don Carlo Gnocchi OnlusScuola Superiore Sant'Anna di Pisa; Fondazione Policlinico Universitario Campus...Not yet recruitingStroke | Stroke Hemorrhagic | Upper Limb Rehabilitation | Stroke IschemicItaly
-
Samsung Medical CenterCompletedChronic Stroke | Subacute Stroke | ExoskeletonSouth Korea
-
University of Illinois at ChicagoRecruitingStroke, Ischemic | Stroke Hemorrhagic | Stroke, CerebrovascularUnited States
-
IRCCS San Camillo, Venezia, ItalyRecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke HemorrhagicItaly
Clinical Trials on Exercise MICT
-
University of MichiganRecruitingObesity | Metabolic Syndrome | Insulin Resistance | Weight Loss | Insulin Sensitivity | Metabolic DiseaseUnited States
-
Dana-Farber Cancer InstituteActive, not recruitingCardiovascular Diseases | Cardiotoxicity | Childhood Cancer Survivors | Anthracycline-induced CardiotoxicityUnited States
-
Riphah International UniversityCompletedPost-cardiac SurgeryPakistan
-
Cambridge Cardiac Care CentreUnknownMyocardial Infarction | Coronary Artery Disease | Diabetes Mellitus, Type 2 | Atrial Fibrillation | Congestive Heart FailureCanada
-
Weifang Medical UniversityNot yet recruiting
-
University of Vermont Medical CenterNational Institute on Aging (NIA)RecruitingHigh Intensity Interval Training | Aerobic CapacityUnited States
-
Cairo UniversityCompleted
-
Ma RuisiNot yet recruitingEsports Players
-
Beijing Sport UniversityCompleted
-
Liverpool John Moores UniversityCompleted